clorazepate dipotassium has been researched along with nalbuphine in 1 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 793 | 269 | 185 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | nalbuphine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
| Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gehrmann, JE; Killam, KF | 1 |
1 other study(ies) available for clorazepate dipotassium and nalbuphine
| Article | Year |
|---|---|
Assessment of CNS drug activity in rhesus monkeys by analysis of the EEG.
Topics: Amobarbital; Animals; Brain; Clorazepate Dipotassium; Codeine; Computers; Electroencephalography; Glutethimide; Haplorhini; Macaca mulatta; Morphine; Nalbuphine; Naloxone; Naltrexone | 1976 |